A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with the Universities of Birmingham,…
Business23 hours ago
Is the CSL (ASX:CSL) share price in the buy zone?
Local News21 hours ago
Miles warns of ‘Delta for Christmas’ if Queensland opens border early
Business20 hours ago
Alarm sounded on house price boom – NEWS.com.au
General17 hours ago
Melbourne tradie who was in ICU with COVID urges protesting construction workers to get vaccinated